Mendel Biotechnology
Revision as of 17:43, 9 June 2010 by Claire Robinson (talk | contribs)
Mendel Biotechnology, Inc. says it aims "to produce plants enhanced for food, feed, fiber, energy and aesthetic benefit without large increases in production acreage" and says it is
- dedicated to being a premier biotechnology company serving large agricultural companies with new genetic and chemical solutions and to becoming the leading seed company serving the bioenergy industry.[1]
Contents
Affiliations
As at June 2010, Mendel's "strategic partners" are:[2]
- Monsanto
- BP
- Bayer CropScience
- Selecta Klemm: a joint venture formed in 2006 — Ornamental Biosciences, Inc. — for the commercialization of ornamental crop varieties differentiated in the marketplace for improved growth and survival under a range of stresses.
- SweTree Technologies: a collaboration for the development of improved varieties of plantation forest tree species.
- ArborGen: a collaboration to improve stress tolerance in selected tree species.
People
Scientific advisory board
As of June 2010:[3]
- Dr. Elliot Meyerowitz
- Dr. Jonathan Jones
- Dr. Brian Staskawicz
- Dr. Fred Ausubel
- Dr. Ulrich Schirmer
- Dr. Andrew Millar
- Dr. Joseph R. Ecker
- Dr. Andrew H. Paterson
- Dr. Charles Wyman
Funding
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
Resources
Notes
- ↑ Our mission, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Scientific Advisory Board, Mendel Biotechnology website, acc 9 Jun 2010
